◀ Back to PCNA
EPO — PCNA
Text-mined interactions from Literome
Wang et al., Eur J Pharmacol 2008
:
Moreover, recombinant human
erythropoietin ( 10, 20 U/ml, 24 h )
promoted the expression of
proliferating cell nuclear antigen in renal tubular cells stimulated by 10 mug/ml aristolochic acid ( 46.34 %, 48.11 % vs. 28.46 % )
Follo et al., Leukemia 2012
(Myelodysplastic Syndromes) :
Here, we investigated the role of inositide pathways in low-risk MDS treated with EPO, mainly focusing on the Akt/PI-PLC ( Phosphoinositide-Phospholipase C ) gamma1 axis, which is
activated by the
EPO receptor, and
PI-PLCbeta1/Cyclin D3 signaling, as Cyclin D3 is associated with hematopoietic proliferation and differentiation